153 related articles for article (PubMed ID: 38720053)
1.
Jeltema HR; van Dijken BRJ; Tamási K; Drost G; Heesters MAAM; van der Hoorn A; Glaudemans AWJM; van Dijk JMC
Ann Nucl Med; 2024 May; ():. PubMed ID: 38720053
[TBL] [Abstract][Full Text] [Related]
2. Study on intracranial meningioma using PET ligand investigation during follow-up over years (SIMPLIFY).
Jeltema HR; Jansen MR; Potgieser ARE; van Asselt ADI; Heesters MAAM; van de Hoorn A; Glaudemans AWJM; van Dijk JMC
Neuroradiology; 2021 Nov; 63(11):1791-1799. PubMed ID: 33694025
[TBL] [Abstract][Full Text] [Related]
3. Correlation of
Mitamura K; Yamamoto Y; Norikane T; Hatakeyama T; Okada M; Nishiyama Y
Ann Nucl Med; 2018 Nov; 32(9):627-633. PubMed ID: 30032455
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of [¹¹C]methionine PET for stereotactic radiation therapy with intensity modulated radiation therapy to metastatic brain tumors.
Miwa K; Matsuo M; Shinoda J; Aki T; Yonezawa S; Ito T; Asano Y; Yamada M; Yokoyama K; Yamada J; Yano H; Iwama T
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1139-44. PubMed ID: 22520479
[TBL] [Abstract][Full Text] [Related]
5. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible?
Tsuyuguchi N; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Takami T; Otsuka Y; Sakamoto S; Ohata K; Goto T; Hara M
J Neurosurg; 2003 May; 98(5):1056-64. PubMed ID: 12744366
[TBL] [Abstract][Full Text] [Related]
6. 18F-FDG and 11C-methionine PET for evaluation of treatment response of lung cancer after stereotactic radiotherapy.
Ishimori T; Saga T; Nagata Y; Nakamoto Y; Higashi T; Mamede M; Mukai T; Negoro Y; Aoki T; Hiraoka M; Konishi J
Ann Nucl Med; 2004 Dec; 18(8):669-74. PubMed ID: 15682847
[TBL] [Abstract][Full Text] [Related]
7. Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.
Tsuyuguchi N; Takami T; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Nishikawa M; Ohata K; Torii K; Morino M; Nishio A; Hara M
Ann Nucl Med; 2004 Jun; 18(4):291-6. PubMed ID: 15359921
[TBL] [Abstract][Full Text] [Related]
8. Effect of 11C-methionine-positron emission tomography on gross tumor volume delineation in stereotactic radiotherapy of skull base meningiomas.
Astner ST; Dobrei-Ciuchendea M; Essler M; Bundschuh RA; Sai H; Schwaiger M; Molls M; Weber WA; Grosu AL
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1161-7. PubMed ID: 18440729
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic radiosurgery versus stereotactic radiotherapy in the management of intracranial meningiomas: a systematic review and meta-analysis.
Fatima N; Meola A; Pollom EL; Soltys SG; Chang SD
Neurosurg Focus; 2019 Jun; 46(6):E2. PubMed ID: 31153149
[TBL] [Abstract][Full Text] [Related]
10. 11C-Methionine Positron Emission Tomography/Computed Tomography Versus 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Evaluation of Residual or Recurrent World Health Organization Grades II and III Meningioma After Treatment.
Tomura N; Saginoya T; Goto H
J Comput Assist Tomogr; 2018; 42(4):517-521. PubMed ID: 29613985
[TBL] [Abstract][Full Text] [Related]
11. Clinical interpretation of residual uptake in 11C-methionine positron emission tomography after treatment of basal ganglia germ cell tumors: report of 3 cases.
Fukuoka K; Yanagisawa T; Watanabe Y; Suzuki T; Matsutani M; Kuji I; Nishikawa R
J Neurosurg Pediatr; 2015 Oct; 16(4):367-71. PubMed ID: 26140394
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of early response to radiotherapy in head and neck cancer measured with [11C]methionine-positron emission tomography.
Nuutinen J; Jyrkkiö S; Lehikoinen P; Lindholm P; Minn H
Radiother Oncol; 1999 Sep; 52(3):225-32. PubMed ID: 10580868
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma.
Nuutinen J; Sonninen P; Lehikoinen P; Sutinen E; Valavaara R; Eronen E; Norrgård S; Kulmala J; Teräs M; Minn H
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):43-52. PubMed ID: 10924970
[TBL] [Abstract][Full Text] [Related]
14. 11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma.
Hatakeyama T; Kawai N; Nishiyama Y; Yamamoto Y; Sasakawa Y; Ichikawa T; Tamiya T
Eur J Nucl Med Mol Imaging; 2008 Nov; 35(11):2009-17. PubMed ID: 18542957
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy.
Terakawa Y; Tsuyuguchi N; Iwai Y; Yamanaka K; Higashiyama S; Takami T; Ohata K
J Nucl Med; 2008 May; 49(5):694-9. PubMed ID: 18413375
[TBL] [Abstract][Full Text] [Related]
16.
Govaerts CW; van Dijken BR; Stormezand GN; van der Weide HL; Wagemakers M; Enting RH; van der Hoorn A
Br J Radiol; 2021 Sep; 94(1125):20210275. PubMed ID: 34233489
[TBL] [Abstract][Full Text] [Related]
17. Methyl-
Niitsu H; Fukumitsu N; Tanaka K; Mizumoto M; Nakai K; Matsuda M; Ishikawa E; Hatano K; Hashimoto T; Kamizawa S; Sakurai H
Ann Nucl Med; 2024 Apr; 38(4):305-314. PubMed ID: 38356008
[TBL] [Abstract][Full Text] [Related]
18. The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysis.
Spohn SKB; Farolfi A; Schandeler S; Vogel MME; Ruf J; Mix M; Kirste S; Ceci F; Fanti S; Lanzafame H; Serani F; Gratzke C; Sigle A; Combs SE; Bernhardt D; Gschwend JE; Buchner JA; Trapp C; Belka C; Bartenstein P; Unterrainer L; Unterrainer M; Eiber M; Nekolla SG; Schiller K; Grosu AL; Schmidt-Hegemann NS; Zamboglou C; Peeken JC
Eur J Nucl Med Mol Imaging; 2022 Dec; 50(1):218-227. PubMed ID: 35984452
[TBL] [Abstract][Full Text] [Related]
19. Lymph node standardized uptake values at pre-treatment
Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW
Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776
[TBL] [Abstract][Full Text] [Related]
20. Correlation of 4'-[methyl-(11)C]-thiothymidine uptake with Ki-67 immunohistochemistry and tumor grade in patients with newly diagnosed gliomas in comparison with (11)C-methionine uptake.
Tanaka K; Yamamoto Y; Maeda Y; Yamamoto H; Kudomi N; Kawai N; Toyohara J; Nishiyama Y
Ann Nucl Med; 2016 Feb; 30(2):89-96. PubMed ID: 26511019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
